The chromatin conformation of the H19 DMD displays prominent nuclease-hypersensitive sites (NHSSs) at the 21 bp repeat conserved in mammals ([5] and references therein). The repeat consensus has some sequence similarity to the CTCF protein target sequences ([9] and references therein). The highly conserved and ubiquitously expressed CTCF protein has 11 Zn-fingers (ZFs). It is an unusual multivalent factor capable of binding to remarkably different and ~50-60 bp long CTS sequences by utilizing different sets of ZFs ([8,9] and references therein). CTSs mediate promoter repression or activation and help to create hormone-responsive silencers ([8,9] and references therein). In addition, core sequences of a number of diverse chromatin insulators in vertebrates have been narrowed down to CTSs [10] . 
Figure 1
Systematic screening of the H19 DMD for CTCF-binding sites. (a) Schematic map of the mouse Igf2-H19 genomic region with functionally relevant regulatory elements and arrangement of consecutive, overlapping DNA fragments, which were each labeled at the 5¢ end. Arrows indicate the activation of each promoter by the H19 enhancers. Numbering is relative to the +1 H19 transcription start. (b) Gel-shift assays with the DMD1 to DMD10 DNA fragments and the 11 ZF domain of CTCF synthesized from the pCITE4a-11ZF vector [9] . Lanes 1, 2, and 3 on each panel correspond to gel-shift reactions with no protein, with the negative luciferase protein control, and with CTCF, respectively. Fragments producing shifted complexes (indicated by arrows) are in red. To test for a link between CTCF and the H19 DMD function, we focused on the second two thirds of the H19 DMD where we could persistently document presence of the NHSSs upstream of NHSS I in mouse fetal liver [5] . We carried out systematic electrophoretic mobility shift assays (EMSA) for CTSs in this H19 region and detected two new CTSs, termed DMD4 and DMD7 (Figure 1 ). To define exactly which sequences are occupied by CTCF, and to identify guanines within these sequences that cannot be modified without losing CTCF binding, we performed DNase I footprinting and methylation interference assays. The results of these experiments, shown in Figure 2 , led us to the following conclusions: first, the positions of the DMD4 and DMD7 CTSs correspond precisely to NHSS I and NHSS II, respectively; second, in each recognition sequence, CTCF protects ~60 bp of both DNA strands from nuclease attack; third, inside of each DMD CTS, CTCF induces DNase-hypersensitivity subsites on the top GC-rich strand; and fourth, in both DMD4 and DMD7 CTSs, the identical CGCG(T/G)GGTG-GCAG core motif provides major contact bases for recognition by CTCF. DMD4 and DMD7 core CTSs contain three and two CpG pairs, respectively, which are methylated in vivo when derived from father [6, 7] . Although the DMD4 and DMD7 CTSs are similar one to another, they are different from several other previously identified CTSs [8] [9] [10] , suggesting a unique contribution of interacting ZFs. Indeed, EMSAs with the proteins containing 12 serial truncations from either end of the 11 ZF domain [9] fully supported this idea (see Supplementary material).
To test whether methylation might interfere with CTCF binding, we modified DMD4 and DMD7 CTS fragments with the SssI methylase and compared them with the unmodified CTS for CTCF binding. Our EMSAs revealed a marked preference of CTCF for the unmethylated DMD sites (Figure 3) . We also quantitatively estimated the effect of CpG methylation on the affinity of CTCF binding to each DMD CTS by surface plasmon resonance using the BIACORE X device. It appeared, quite unexpectedly, that the best-fit model for CTCF-DNA interaction is the two-stage reaction, with an intermediate conformational change resulting in formation of stable non-dissociating complexes with an apparent affinity constant in the range of 10 11 to 10 13 M -1 . In contrast, CTCF binding to the methylated DMD4 and DMD7 sites was at least a 1,000-fold lower in affinity (~10 8 M -1 ), and no stable complexes with methylated probes were detected (data not shown). CTCF affinity to methylated DMDs was still high enough to detect some residual binding by EMSAs not designed to measure the on-andoff binding rates (see Supplementary material).
To determine whether the H19 DMD CTS sequences display the chromatin-insulator-like activity, we generated Brief Communication 855 (c) Quantitation of enhancer-blocking assay normalized to DNA input and episome copy number. The SV40 enhancer-driven expression of the pREPH19A construct was, for convenience, assigned a value of 100 while all other samples were normalized relative to this value. The mean deviation of at least three different experiments is indicated for each vector construct, unless the differences were too insignificant to show. 
Current Biology point mutations that eliminate CTCF interaction with the DMD4 and DMD7 sites. Figure 4a shows that changing the sequence GTGG to ATAT in either of the DMD CTSs (see Figure 2c ) destroyed their interaction with CTCF. Next, we addressed whether the enhancer-blocking properties of the H19 DMD depend on the CTSs in an episomal-based assay [5] . As could be expected, the targeted disruption of CTCF-DMD interaction at both CTS counteracted most of the enhancer-blocking properties of the H19 5¢ flank (Figure 4b,c) .
To examine an in vivo link between CTCF and the H19 5¢ flank, we analyzed the distribution of CTCF in formaldehyde-crosslinked chromatin of fetal livers of reciprocal M. musculus musculus (M)´ M. musculus domesticus (D) intraspecific hybrid crosses (see Figure 5 legend). CTCFimmunoprecipitated DNA was analyzed by a PCR assay, which allowed the discrimination of the parental alleles of the H19 5¢ flank by exploiting a polymorphic restriction site, BsmAI [5] . Figure 5 shows that only the maternally inherited allele (the M allele in the M´ D cross) is specifically captured by the CTCF antibody. When the opposite cross (D´ M) was examined, the D allele was preferentially amplified. Given that the average length of the sonicated DNA fragments was 2-3 kb, most if not all of the potential CTCF-binding sites scattered within the DMD of the H19 5¢ flank are likely to be covered in this assay. We conclude that the CTCF interaction with the H19 5¢ flank is parent of origin-specific.
We have shown here that CTCF is both structurally and functionally an integral part of the H19 DMD chromatin conformation and that its parent of origin-dependent interaction with the H19 insulator is likely to involve its ability to read the methylation mark. It is tempting to speculate that function of CTCF as a candidate tumor suppressor gene at chromosome segment 16q22.1, where the predicted third Wilms' tumor gene (WT3) is localized, and frequent loss of Igf2/H19 imprinting in these tumors ( [8] and references therein) may be causally linked. Although our data implicate CTCF in manifesting the repressed status of the maternal Igf2 allele in the soma, this remains to be demonstrated in targeted deletion mouse models.
Supplementary material
Supplementary material including figures showing the combinations of ZFs required to bind different DMDs and the methylation-sensitivity of CTCF binding to DMDs, and additional discussion and methodological details, is available at http://current-biology.com/supmat/supmatin.htm. 
